Week38, 2023
1. Influenza activity is low, with 0.9% of clinical specimens testing positive, of which 59.4% are Influenza A and 40.6% Influenza B.
2. Public health labs identified 72 positive specimens; 65.3% were Influenza A and 34.7% Influenza B, with 94.1% of Influenza A subtyped as (H1N1)pdm09.
3. Nationwide, 2.0% of outpatient visits reported were for influenza-like illness (ILI), with the highest rates among children aged 0-4 years (6.8%).
4. 880 laboratory-confirmed influenza-related hospitalizations were reported for week 38.
5. Deaths attributed to pneumonia, influenza, or COVID-19 (PIC) accounted for 7.2%, exceeding the epidemic threshold of 5.6%; 10 deaths were influenza-related.
6. No influenza-associated pediatric deaths were reported this week; the season total remains at 176.
7. Influenza B was exclusively classified under the Victoria lineage this week, continuing the absence of Yamagata lineage detections.
8. Multiple respiratory viruses, including SARS-CoV-2 and RSV, are co-circulating, contributing variably to ILI activity across regions.
9. CDC emphasizes vaccination but has not reported significant updates on vaccination uptake or impact on trends.
10. Flu activity is expected to stay low but may vary regionally due to co-circulating respiratory viruses and healthcare-seeking behavior patterns.